ES2254224T3 - Nueva proteina del receptor de hematopoyetina, nr12. - Google Patents
Nueva proteina del receptor de hematopoyetina, nr12.Info
- Publication number
- ES2254224T3 ES2254224T3 ES00962878T ES00962878T ES2254224T3 ES 2254224 T3 ES2254224 T3 ES 2254224T3 ES 00962878 T ES00962878 T ES 00962878T ES 00962878 T ES00962878 T ES 00962878T ES 2254224 T3 ES2254224 T3 ES 2254224T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- baselineskip
- dna
- sequence
- sneg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27335899 | 1999-09-27 | ||
JP11-273358 | 1999-09-27 | ||
JP2000-240397 | 2000-08-03 | ||
JP2000240397 | 2000-08-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2254224T3 true ES2254224T3 (es) | 2006-06-16 |
Family
ID=26550628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES00962878T Expired - Lifetime ES2254224T3 (es) | 1999-09-27 | 2000-09-27 | Nueva proteina del receptor de hematopoyetina, nr12. |
Country Status (6)
Country | Link |
---|---|
US (9) | US7045595B2 (fr) |
EP (1) | EP1221482B1 (fr) |
AU (1) | AU7445900A (fr) |
DE (1) | DE60025241T2 (fr) |
ES (1) | ES2254224T3 (fr) |
WO (1) | WO2001023556A1 (fr) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1181366T4 (da) * | 1999-06-01 | 2013-09-23 | Merck Sharp & Dohme | Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder |
ES2339843T3 (es) | 1999-06-02 | 2010-05-26 | Chugai Seiyaku Kabushiki Kaisha | Proteina receptora de hematopoyetina novedosa, nr10. |
AU2007202362B2 (en) * | 1999-09-03 | 2011-06-23 | Merck Sharp & Dohme Corp. | Mammalian receptor proteins; related reagents and methods |
ES2254224T3 (es) * | 1999-09-27 | 2006-06-16 | Chugai Seiyaku Kabushiki Kaisha | Nueva proteina del receptor de hematopoyetina, nr12. |
ES2307618T3 (es) | 2000-05-10 | 2008-12-01 | Schering Corporation | Proteinas subunidades de receptores de cotocinas de mamiferos, reactivos y metodos relacionados. |
US7422743B2 (en) * | 2000-05-10 | 2008-09-09 | Schering Corporation | Mammalian receptor protein DCRS5;methods of treatment |
AU2318202A (en) * | 2000-10-06 | 2002-04-15 | Immunex Corp | Hematopoietin receptors hpr1 and hpr2 |
CA2501786C (fr) | 2002-10-30 | 2015-02-17 | Genentech, Inc. | Inhibition de la production d'il-17 |
WO2004101606A2 (fr) * | 2003-05-12 | 2004-11-25 | Affymax, Inc. | Nouveaux peptides se fixant au recepteur de l'erythropoietine |
KR101227666B1 (ko) * | 2003-05-12 | 2013-01-31 | 아피맥스, 인크. | 에리스로포이에틴 수용체에 결합하는 펩티드 |
CA2525464A1 (fr) | 2003-05-12 | 2004-11-25 | Qun Yin | Nouveaux composes modifies par du poly(ethylene glycol) et leurs utilisations |
EP2204193A3 (fr) * | 2003-05-12 | 2010-08-18 | Affymax, Inc. | Groupe espaceur pour composés à base de peptides de poly(éthylèneglycol) modifiés |
CN101142234A (zh) * | 2004-11-11 | 2008-03-12 | 阿费麦克斯公司 | 结合红细胞生成素受体的新肽 |
WO2006062685A2 (fr) * | 2004-11-11 | 2006-06-15 | Affymax, Inc. | Nouveaux peptides se liant au recepteur de l'erythropoietine |
US20060257935A1 (en) * | 2005-04-26 | 2006-11-16 | Ajinomoto Co., Inc. | Hematopoietic factor production promoter |
US8324159B2 (en) * | 2005-06-03 | 2012-12-04 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
US7919461B2 (en) | 2005-06-03 | 2011-04-05 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
US7550433B2 (en) | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
DK2047863T3 (da) | 2006-06-08 | 2013-09-16 | Chugai Pharmaceutical Co Ltd | Middel til forebyggelse eller behandling af inflammatoriske sygdomme |
JP2010520855A (ja) * | 2007-01-31 | 2010-06-17 | アフィーマックス・インコーポレイテッド | 修飾基をポリペプチドおよびその他の高分子に結合するための窒素ベースのリンカー |
NZ579251A (en) | 2007-02-28 | 2012-06-29 | Schering Corp | Engineered anti-il-23r antibodies |
JP5337055B2 (ja) | 2007-02-28 | 2013-11-06 | メルク・シャープ・アンド・ドーム・コーポレーション | 免疫性障害の処置のための組合せ治療 |
EP2288621A4 (fr) * | 2007-07-06 | 2012-01-04 | Valorisation Hsj Soc En Commandite | Antagonistes du récepteur de l'il-23 et leurs utilisations |
CN101939025B (zh) | 2007-12-05 | 2015-03-25 | 中外制药株式会社 | 搔痒症治疗药 |
KR20150002874A (ko) | 2008-05-05 | 2015-01-07 | 노비뮨 에스 에이 | 항-il-17a/il-17f 교차-반응성 항체 및 그의 사용 방법 |
US20110158992A1 (en) * | 2008-08-27 | 2011-06-30 | Schering Corporation | Engineered Anti-IL-23R Antibodies |
EP2427203B1 (fr) | 2009-05-05 | 2018-10-17 | Novimmune S.A. | Anticorps anti-il-17f et leurs utilisation |
CN102206667B (zh) * | 2011-04-18 | 2012-10-10 | 中国药科大学 | 重组质粒pET32a-hIL-23R-CHR及其构建表达 |
TW202327654A (zh) | 2015-04-14 | 2023-07-16 | 日商中外製藥股份有限公司 | 含有il-31拮抗劑作為有效成分之異位性皮膚炎的預防用及/或治療用醫藥組合物 |
EP3232000A1 (fr) | 2016-04-15 | 2017-10-18 | Siemens Aktiengesellschaft | Plateforme d'une aube comprenant des trous de refroidissement a film et turbomachine associée |
JP6845973B1 (ja) | 2019-11-20 | 2021-03-24 | 中外製薬株式会社 | 抗体含有製剤 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4732863A (en) * | 1984-12-31 | 1988-03-22 | University Of New Mexico | PEG-modified antibody with reduced affinity for cell surface Fc receptors |
JP2898064B2 (ja) | 1989-08-03 | 1999-05-31 | 忠三 岸本 | ヒトgp130蛋白質 |
GB9016440D0 (en) | 1990-07-26 | 1990-09-12 | Elopak Systems | A laminate |
US5783672A (en) | 1994-05-26 | 1998-07-21 | Immunex Corporation | Receptor for oncostatin M |
AUPN481295A0 (en) * | 1995-08-16 | 1995-09-07 | Medvet Science Pty. Ltd. | Agonists of haemopoietic growth factors |
AUPN564195A0 (en) * | 1995-09-26 | 1995-10-19 | Walter And Eliza Hall Institute Of Medical Research, The | A novel haemopoietin receptor and genetic sequences encoding same |
WO1997015663A1 (fr) * | 1995-10-23 | 1997-05-01 | Amrad Operations Pty. Ltd. | Nouveau recepteur d'hematopoietine et sequences genetiques le codant |
US6642360B2 (en) * | 1997-12-03 | 2003-11-04 | Genentech, Inc. | Secreted polypeptides that stimulate release of proteoglycans from cartilage |
US6747137B1 (en) * | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
WO1999067290A1 (fr) | 1998-06-24 | 1999-12-29 | Chugai Research Institute For Molecular Medicine, Inc. | Nouvelles proteines receptrices d'hemopoïetine |
DK1181366T4 (da) * | 1999-06-01 | 2013-09-23 | Merck Sharp & Dohme | Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder |
US20030082734A1 (en) * | 1999-06-01 | 2003-05-01 | Dowling Lynette M. | Mammalian receptor proteins; related reagents and methods |
ES2339843T3 (es) | 1999-06-02 | 2010-05-26 | Chugai Seiyaku Kabushiki Kaisha | Proteina receptora de hematopoyetina novedosa, nr10. |
ES2254224T3 (es) * | 1999-09-27 | 2006-06-16 | Chugai Seiyaku Kabushiki Kaisha | Nueva proteina del receptor de hematopoyetina, nr12. |
ES2307618T3 (es) * | 2000-05-10 | 2008-12-01 | Schering Corporation | Proteinas subunidades de receptores de cotocinas de mamiferos, reactivos y metodos relacionados. |
WO2002000721A2 (fr) | 2000-06-26 | 2002-01-03 | Zymogenetics, Inc. | Zcytor17, recepteur de la cytokine |
AU2318202A (en) | 2000-10-06 | 2002-04-15 | Immunex Corp | Hematopoietin receptors hpr1 and hpr2 |
WO2002077230A1 (fr) | 2001-03-26 | 2002-10-03 | Chugai Seiyaku Kabushiki Kaisha | Variants d'epissage nr10 |
BR0306979A (pt) | 2002-01-18 | 2004-11-23 | Zymogenetics Inc | Polipeptìdeo isolado, proteìna de fusão, molécula isolada de polinucleotìdeo, vetor de expressão, célula cultivada, anticorpo ou fragmento de anticorpo, e, métodos para produzir uma proteìna, para produzir um anticorpo, para estimular uma resposta imune em um mamìfero, para expandir células hematopoiéticas e progenitores de células hematopoiéticas, para detectar a presença de rna zcytor17lig e de zcytor17lig em uma amostra biológica, para matar cérlulas cancerìgenas, para inibir a proliferação induzida por zcytor17lig ou diferenciação de células hematopoiéticas e progenitoras de células hematopoiéticas, para reduzir a inflamação induzida por zcytor17lig para suprimir uma resposta inflamatória em um mamìfero com inflamação, para tratar um mamìfero acometido por uma doença inflamatória e para detectar inflamação em um paciente |
AU2003280410B8 (en) | 2002-01-18 | 2009-04-23 | Zymogenetics, Inc. | Cytokine receptor zcytor17 multimers |
SI1485477T1 (sl) | 2002-02-25 | 2009-10-31 | Genentech Inc | Novi citokinski receptor GLM-R tipa 1 |
US7579000B2 (en) * | 2002-05-01 | 2009-08-25 | Bayer Schering Pharma Ag | Tissue factor targeted antibodies as anticoagulants |
CA2483909A1 (fr) * | 2002-05-01 | 2003-11-13 | Schering Aktiengesellschaft | Nouvelles proteines de fusion de thrombomoduline ciblees sur le facteur tissulaire comme anticoagulants |
EP1671642A1 (fr) | 2004-12-15 | 2006-06-21 | Universite D'angers | Composés contenant des (ant)agonistes de l'oncostatin M (OSM), IL-31 et IFN-gamma pour moduler la migration et fonction de keratinocytes au moyen d'un recepteur comprenant l'OSMRbeta comme sousunité, et applications correspondantes |
AU2006207945B2 (en) | 2005-01-28 | 2012-02-09 | Zymogenetics, Inc. | Homogeneous preparations of IL-31 |
EP1856539B1 (fr) | 2005-02-14 | 2015-10-21 | ZymoGenetics, Inc. | Procedes de prediction de reponse therapeutiques dans la dermatite atopique aux antagonistes il-31 |
WO2006088855A1 (fr) | 2005-02-14 | 2006-08-24 | Zymogenetics, Inc. | Méthodes de traitement d’affections de la peau en employant un antagoniste de il-31ra |
ES2561628T3 (es) | 2005-05-06 | 2016-02-29 | Zymogenetics, Inc. | Anticuerpos monoclonales IL-31 y métodos de uso |
CA2636288C (fr) | 2006-01-10 | 2015-02-24 | Zymogenetics, Inc. | Procedes de traitement de la douleur et de l'inflammation dans les tissus neuronaux au moyen d'antagonistes de l'il-31 |
DK2047863T3 (da) * | 2006-06-08 | 2013-09-16 | Chugai Pharmaceutical Co Ltd | Middel til forebyggelse eller behandling af inflammatoriske sygdomme |
TWI434703B (zh) * | 2007-05-14 | 2014-04-21 | Kao Corp | 皮膚洗淨劑組成物 |
JP5132292B2 (ja) * | 2007-12-07 | 2013-01-30 | キヤノン株式会社 | 情報処理装置および情報処理方法 |
-
2000
- 2000-09-27 ES ES00962878T patent/ES2254224T3/es not_active Expired - Lifetime
- 2000-09-27 WO PCT/JP2000/006654 patent/WO2001023556A1/fr active IP Right Grant
- 2000-09-27 DE DE60025241T patent/DE60025241T2/de not_active Expired - Lifetime
- 2000-09-27 EP EP00962878A patent/EP1221482B1/fr not_active Expired - Lifetime
- 2000-09-27 AU AU74459/00A patent/AU7445900A/en not_active Abandoned
-
2002
- 2002-03-25 US US10/105,930 patent/US7045595B2/en not_active Expired - Lifetime
-
2005
- 2005-11-14 US US11/274,375 patent/US20060106201A1/en not_active Abandoned
-
2006
- 2006-11-09 US US11/595,320 patent/US7893201B2/en not_active Expired - Fee Related
-
2008
- 2008-09-05 US US12/205,799 patent/US7893205B2/en not_active Expired - Fee Related
- 2008-09-05 US US12/205,753 patent/US20090029484A1/en not_active Abandoned
- 2008-12-01 US US12/325,617 patent/US20090105458A1/en not_active Abandoned
- 2008-12-01 US US12/325,591 patent/US20090105457A1/en not_active Abandoned
- 2008-12-01 US US12/325,631 patent/US20090105459A1/en not_active Abandoned
- 2008-12-01 US US12/325,556 patent/US20090111972A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU7445900A (en) | 2001-04-30 |
DE60025241D1 (de) | 2006-02-02 |
WO2001023556A1 (fr) | 2001-04-05 |
US20090105457A1 (en) | 2009-04-23 |
EP1221482B1 (fr) | 2005-12-28 |
US20030009018A1 (en) | 2003-01-09 |
US20090029484A1 (en) | 2009-01-29 |
US20090105459A1 (en) | 2009-04-23 |
DE60025241T2 (de) | 2007-01-11 |
US7045595B2 (en) | 2006-05-16 |
US20090023660A1 (en) | 2009-01-22 |
US7893201B2 (en) | 2011-02-22 |
EP1221482A4 (fr) | 2003-03-26 |
US7893205B2 (en) | 2011-02-22 |
US20070203328A1 (en) | 2007-08-30 |
US20060106201A1 (en) | 2006-05-18 |
US20090105458A1 (en) | 2009-04-23 |
US20090111972A1 (en) | 2009-04-30 |
EP1221482A1 (fr) | 2002-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2254224T3 (es) | Nueva proteina del receptor de hematopoyetina, nr12. | |
ES2339843T3 (es) | Proteina receptora de hematopoyetina novedosa, nr10. | |
EP1088831A1 (fr) | Nouvelles proteines receptrices d'hemopo etine | |
US20090197317A1 (en) | TSG-Like Gene | |
US8242245B2 (en) | Fetal polypeptides from human liver | |
JP2008099690A (ja) | 新規ヘモポエチン受容体蛋白質、nr12 |